PR Newswire
MISSISSAUGA, Ontario, Feb. 16, 2017
MISSISSAUGA, Ontario, Feb. 16, 2017 /PRNewswire/ -- Aralez
Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that
executive management will participate in the RBC Capital Markets Global Healthcare Conference to be held February 22-23, 2017. Adrian Adams, Chief Executive Officer, will provide an
overview of the Company at 1:35 p.m. local time on Wednesday, February 22,
2017.
A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of
the presentation to ensure adequate time for any software downloads that may be necessary to listen to the
webcast.
About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering
meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing
products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Mississauga, Ontario, Canada, its U.S. Headquarters is in Princeton, NJ and
the Ireland Headquarters is in Dublin, Ireland. More information about Aralez can be found at
www.aralez.com.
Contact Information:
Aralez Pharmaceuticals US Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications
609.917.9303
nochsner@aralez.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-rbc-capital-markets-global-healthcare-conference-300408985.html
SOURCE Aralez Pharmaceuticals Inc.
